LEADER 01306nam2-2200421---45--
001 990000999330203316
005 20110520181612.0
010   $a978-3-642-13442-5
035   $a0099933
035   $aUSA010099933
035   $a(ALEPH)000099933USA01
035   $a0099933
100   $a20020227d2011----km-y0itay50------ba
101   $aeng
102   $aDE
105   $a||||||||001yy
200 1 $aMethylxanthines$fBertil B. Fredholm editor
210   $aBerlin$aHeidelberg$cSpringer$d2011
215   $aXV, 559 p.$cill.
225 2 $aHandbook of experimental pharmacology$v200
410  0$1001000320432$aHandbook of experimental pharmacology$v, 200
606 0 $aMetilxantine$xFarmacoterapia
676   $a615.78
702  1$aFREDHOLM,$bBertil B.
801  0$aIT$bsalbc$gISBD
912   $a990000999330203316
951   $a615.78 MET 1$b5436 Farm.$c615.78 MET 1$d00165997
959   $aBK
969   $aFAR
979   $aPATTY$b90$c20020227$lUSA01$h0958
979   $c20020403$lUSA01$h1741
979   $aPATRY$b90$c20040406$lUSA01$h1709
979   $aRSIAV3$b90$c20090624$lUSA01$h1743
979   $aRSIAV3$b90$c20090624$lUSA01$h1747
979   $aPATRY$b90$c20110520$lUSA01$h1757
979   $aPATRY$b90$c20110520$lUSA01$h1816
996   $aMethylxanthines$9975361
997   $aUNISA